Angiomyolipoma overview: Difference between revisions

Jump to navigation Jump to search
Line 26: Line 26:


==History and Symptoms==
==History and Symptoms==
Symptoms of [[angiomyolipoma]] include [[nausea]], [[vomiting]], and [[abdominal pain]].


==Physical Examination==
==Physical Examination==

Revision as of 17:50, 23 September 2015

Angiomyolipoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Angiomyolipoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Angiomyolipoma overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Angiomyolipoma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Angiomyolipoma overview

CDC on Angiomyolipoma overview

Angiomyolipoma overview in the news

Blogs on Angiomyolipoma overview

Directions to Hospitals Treating Angiomyolipoma

Risk calculators and risk factors for Angiomyolipoma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2], Faizan Sheraz, M.D. [3]

Overview

Angiomyolipoma is a benign renal neoplasm previously considered to be a hamartoma or choristoma, but now known to be neoplastic.[1] It is composed of variable amounts of fat, vascular, and smooth muscle elements. The fat density of the tumour on CT has been regarded to be pathognomonic, although there are now case reports of renal cell carcinoma types also possessing macroscopic fat. The lesion is well demarcated and contains mature elements. It occurs in more than 50% of individuals with tuberous sclerosis, often bilaterally. Angiomyolipomata also occur in 40% of women who have a rare, cystic lung disease called lymphangioleiomyomatosis, or LAM.[2]

Classification

Angiomyolipoma may be classified according to etiology into: tuberous sclerosis associated and isolated angiomyolipoma.

Pathophysiology

On gross pathology, well circumscribed and uniform yellow mass are characteristic findings of angiomyolipoma.

Causes

Angiomyolipoma is caused by a defect in the TSC1 gene. It can also be caused by a defect in another gene:TSC2.

Differentiating Angiomyolipoma from other Diseases

Angiomyolipoma must be differentiated from retroperitoneal liposarcoma, adrenal myelolipoma, and renal cell carcinoma.

Epidemiology and Demographics

The incidence is approximately 30 per 100,000 individuals worldwide. Women are more commonly affected with angiomyolipoma than men.

Risk Factors

Natural History, Complications and Prognosis

If left untreated, small angiomyolipomas and those without dilated blood vessels (aneurysms) cause few problems. Small angiomyolipomas are associated with the most favorable prognosis.Common complications of angiomyolipoma include infection, hematuria and flank pain.

History and Symptoms

Symptoms of angiomyolipoma include nausea, vomiting, and abdominal pain.

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Diagnostic Studies

Medical Therapy

There is no treatment for angiomyolipoma; the mainstay of therapy is surgical resection or embolisation.

Surgery

Surgery is not the first-line treatment option for patients with angiomyolipoma. Transcatheter arterial embolization is usually reserved for patients with complicated disease.[3]

References

  1. Eble JN. Angiomyolipoma of the kidney. Semin Diagn Pathol 1988;15:21-40
  2. McCormack FX (2006). "Lymphangioleiomyomatosis". MedGenMed. 8 (1): 15. PMC 1682009. PMID 16915145.
  3. Lewis JH, Weingold AB (1985). "The use of gastrointestinal drugs during pregnancy and lactation". Am J Gastroenterol. 80 (11): 912–23. PMID 2864852.


Template:WikiDoc Sources